DMD and dilated cardiomyopathy: The incidence of skeletal muscle damage among female carriers of loss-of-function DMD mutations, including asymptomatic carriers, was reported as between 2.5% and 19%, and the incidence of dilated cardiomyopathy as between 7.3% and 16.7% (reviewed by Ishizaki et al., 2018).